|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.59 EUR | +0.38% |
|
-1.74% | -7.41% |
| 12:36am | Sanofi - Shareholder/Analyst Call | |
| 06:22pm | FDA approves expanded use of Sanofi's type 1 diabetes drug | RE |
| Market Cap | 91.92B 106B 84.71B 79.29B 149B 10,116B 151B 1,000B 390B 4,924B 399B 391B 17,049B | P/E Ratio 2026 * |
11.4x | P/E Ratio 2027 * | 10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 103B 119B 94.66B 88.61B 166B 11,305B 169B 1,118B 436B 5,503B 446B 437B 19,053B | EV / Sales 2026 * |
2.18x | EV / Sales 2027 * | 2x |
| Free-Float |
89% | Yield 2026 * |
5.56% | Yield 2027 * | 5.89% |
Last Transcript: Sanofi
| 1 day | +0.38% | ||
| 1 week | -1.74% | ||
| Current month | +1.73% | ||
| 1 month | +4.40% | ||
| 3 months | +0.09% | ||
| 6 months | -8.08% | ||
| Current year | -7.41% |
| 1 week | 74.91 |  | 78.26 |
| 1 month | 72.61 | | 78.43 |
| Current year | 71.73 | | 84.97 |
| 1 year | 71.73 | | 91.15 |
| 3 years | 71.73 | | 110.88 |
| 5 years | 71.73 | | 110.88 |
| 10 years | 62.5 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 2026-04-30 | |
| Director of Finance/CFO | 64 | 2024-03-31 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 2023-09-10 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 2019-04-29 | |
Rachel Duan
BRD | Director/Board Member | 56 | 2020-04-27 |
Lise Kingo
BRD | Director/Board Member | 64 | 2020-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 05 | Buy | 169 | 0.0000% | |||
| Jun. 05 | Buy | Chief Financial Officer | 70 | 0.0000% | ||
| May. 30 | Buy | Executive/Senior Manager | 27 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | -1.74% | -12.65% | -19.40% | 106B | |
| -2.41% | +0.14% | +39.53% | +154.43% | 1,010B | |
| +1.07% | +3.48% | +53.75% | +50.64% | 580B | |
| +1.32% | +0.22% | +18.35% | +65.35% | 402B | |
| +0.77% | 0.00% | +19.99% | +16.80% | 330B | |
| -1.42% | -1.44% | +45.50% | +8.37% | 294B | |
| -0.85% | -2.86% | +22.05% | +13.80% | 280B | |
| +0.44% | +3.48% | +24.48% | +34.39% | 281B | |
| +1.66% | +1.20% | -44.67% | -47.49% | 197B | |
| +0.32% | +1.61% | +19.48% | +63.42% | 192B | |
| Average | -0.22% | +0.72% | +18.58% | +34.03% | 367.35B | |
| Weighted average by Cap. | -0.77% | +0.92% | +28.61% | +63.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.07B 54.5B 43.37B 40.6B 76.09B 5,180B 77.26B 512B 200B 2,521B 205B 200B 8,730B | 49.98B 57.87B 46.06B 43.11B 80.79B 5,500B 82.04B 544B 212B 2,677B 217B 213B 9,270B |
| Net income | 8.15B 9.43B 7.51B 7.03B 13.17B 896B 13.37B 88.63B 34.55B 436B 35.39B 34.64B 1,511B | 8.95B 10.37B 8.25B 7.72B 14.48B 985B 14.7B 97.44B 37.99B 480B 38.91B 38.08B 1,661B |
| Net Debt | 10.8B 12.51B 9.96B 9.32B 17.46B 1,189B 17.73B 118B 45.83B 579B 46.94B 45.94B 2,004B | 8.08B 9.36B 7.45B 6.97B 13.07B 890B 13.27B 87.95B 34.29B 433B 35.12B 34.38B 1,499B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 76.59 € | +0.38% | 2,580,601 |
| 26-06-11 | 76.30 € | +0.38% | 2,383,389 |
| 26-06-10 | 76.01 € | -1.34% | 3,548,747 |
| 26-06-09 | 77.04 € | +0.48% | 2,677,806 |
| 26-06-08 | 76.67 € | -1.64% | 2,289,535 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
